Different stages in drug development for muscle-invasive bladder cancer

Muscle-invasive bladder cancer (MIBC) is a highly aggressive disease. Despite optimal therapy, half of the patients will succumb to disease. This prognosis could not be improved over the last three decades. Therefore, MIBC is left behind from other cancers such as prostate, where novel treatment opt...

Descripción completa

Detalles Bibliográficos
Autores principales: Ineichen, Gallus Beatus, Röthlisberger, Raphael, Johner, Kevin Fabian, Seiler, Roland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760381/
https://www.ncbi.nlm.nih.gov/pubmed/29354493
http://dx.doi.org/10.21037/tau.2017.11.22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760381/
https://www.ncbi.nlm.nih.gov/pubmed/29354493
http://dx.doi.org/10.21037/tau.2017.11.22

Ejemplares similares